| Metric | Value | Source |
|---|---|---|
| Total US healthcare spending (2024) | $5.3 trillion ($15,474/capita, 18% of GDP) | CMS1 |
| Medicare + Medicaid combined | $2.05 trillion (39% of NHE) | CMS1 |
| Medicare hospital reimbursement | $0.83 per $1.00 of cost | AHA2 |
| Medicare + Medicaid hospital shortfall | $130 billion/year | AHA2 |
| Hospitals with negative Medicare margins | 67% | AHA2 |
| Medicare FFS hospital margin (2023) | -13% | MedPAC3 |
| Administrative spending (2017) | $812 billion (34.2% of NHE) | Annals of Internal Medicine4 |
| Canada administrative spending | 17% of NHE | Woolhandler et al.4 |
| Healthcare waste from admin complexity | $265.6 billion/yr | JAMA5 |
| Top 5% of patients, share of spending | 49.7% | AHRQ6 |
| Top 10% of patients, share of spending | 65.9% | AHRQ6 |
A small fraction of the population drives the majority of healthcare costs. The top 10% of patients account for nearly two-thirds of all spending.6 These patients are disproportionately served by Medicare and Medicaid.
Providers lose money serving them. Two-thirds of hospitals operate at a loss on Medicare patients.2 The combined government shortfall is $130 billion per year. These are not charitable organizations absorbing losses out of mission — they are businesses dealing with a loss leader that represents their largest patient segment.
The system stays solvent through cost-shifting. Hospitals charge private insurers significantly more than Medicare rates to subsidize government patient losses. MedPAC data confirms this: hospital all-payer margin is +6.4% despite a -13% Medicare margin.3 Private insurance is the cross-subsidy.
This optimization pressure — maximize private payer revenue to cover government losses — drives coding complexity, documentation requirements, and administrative overhead, which drives up costs for everyone.
That was $812 billion in 2017.4 Adjusted for the growth to $5.3T total spending, the current figure is well over $1 trillion annually.
A 2014 eight-nation study found US hospital administrative costs were 25.3% of total hospital expenditures, compared to approximately 12% in Canada and Scotland.11 Reducing US hospital admin to Canadian levels would save over $150 billion per year in hospital spending alone.
JAMA estimated $265.6 billion per year in pure administrative waste — not total admin, just the excess.5 It is the single largest category of waste in US healthcare, ahead of clinical waste, fraud, and overtreatment.
The insurance system built complexity as a cost control mechanism. Prior authorizations, denial workflows, appeals processes, credentialing requirements, payer-specific formularies and rules — these are speedbumps designed to create attrition. A denied claim that never gets appealed is money the payer keeps.
| Metric | Value | Source |
|---|---|---|
| Prior auth requests per physician per week | 39 | AMA7 |
| Staff hours/week spent on prior auth per physician | 13 hours | AMA7 |
| Physicians reporting PA increases burnout | 89% | AMA7 |
| Physicians reporting PA delays care | 93% | AMA7 |
| PA-related serious adverse events | 27% of physicians report | AMA7 |
| Program | Prior Auth Denial Rate | Source |
|---|---|---|
| Medicaid Managed Care (avg) | 12.5% (range: 6-34% by MCO) | HHS OIG8 |
| Medicare Advantage (2024) | 7.7% | KFF9 |
| ACA Marketplace (all claims, 2023) | 19% (range: 1-54%) | KFF10 |
| Metric | Value | Source |
|---|---|---|
| Medicare Advantage denials never appealed | 88% | KFF9 |
| ACA Marketplace denials never appealed | 99% | KFF10 |
| Appeals that succeed when actually filed (MA) | 82% | KFF9 |
When providers actually appeal, they win 82% of the time. The denials are not clinically justified — they are friction. And the friction works because 88-99% of denied claims are never challenged.
This is by design. Every denied claim requires a person to read the denial, pull the chart, write the appeal, fax it, follow up. The speedbumps work because humans are slow and expensive to throw at the problem.
The only guaranteed winners are the administrative infrastructure itself.
Large health systems can brute-force this with headcount — dedicated rev cycle teams, coding departments, compliance officers. They have built their own maze-running infrastructure.
Small to midsized organizations cannot. A 5-provider behavioral health clinic, a rural hospital, a small SUD treatment center — they face the same complexity as a 500-bed system without the resources to absorb it. The administrative burden is disproportionately destructive at this scale.
Uwe Reinhardt (Princeton health economist) documented a telling comparison: a McGill-affiliated hospital complex managing 39,000 inpatients per year with 12 billing staff, versus an equivalent US hospital requiring 800-900 billing staff for the same volume.12
Payers deny claims and hide behind "the provider didn't follow the process." Most of the time they are technically right — because the process is deliberately byzantine and providers miss steps. The payer wins by default.
But the rules themselves are often contradictory. Policies don't match actual denial behavior. Stated criteria conflict with applied criteria. The system relies on providers not having the bandwidth to notice, document, or challenge these contradictions at scale.
Underpayment and denial friction are two mechanisms that extract value from providers. The third is regulatory capture — the process by which the entities being regulated shape the rules to serve their own interests.
The healthcare industry is the largest lobbying sector in the United States. In 2023, the health sector spent $739 million on lobbying. Pharma and health products accounted for $385.6 million; health insurance contributed $129.3 million. Among the top spenders in 2024: PhRMA ($24M), AHA ($21.3M), AMA ($18.1M), BCBS ($49.5M), UnitedHealth Group ($16.6M), and AdvaMed ($4.13M).13
The organizations shaping this framework — FDA, ONC, AHA, AdvaMed, AMIA — are not disinterested parties. Several are trade groups that actively lobby for their members' commercial interests. The framework they are shaping will determine who can sell AI into healthcare and at what compliance cost.
A 2023 Health Affairs study — the first to systematically quantify personnel movement between HHS and industry — found that 15% of HHS appointees entered from private industry, but 32% exited to industry at end of tenure. At CMS specifically, more than half of appointees departed for private industry. At the CDC, 54% left for industry.14
At the FDA, a 2018 Science investigation found 11 of 16 medical examiners who worked on 28 drug approvals and subsequently left the agency now work for or consult for the companies they regulated.15 A Stanford Law & Policy Review article documented the legal framework for how this creates both conscious and unconscious bias in regulatory decisions.16
The pattern is consistent: regulators build expertise on the public payroll, then monetize that expertise — and their relationships — in the private sector. The rules they write while in government reflect the institutional knowledge of where they expect to work next.
A GAO audit found that over half of FDA advisory committee meetings had at least one member with a financial conflict of interest. Across 83 meetings examined, 16% of all participants had conflicts.17 A separate JAMA study of 221 FDA Drug Advisory Committee meetings found 73% had at least one conflicted member and 28% of voting members had financial conflicts.18
The AMA's Relative Value Scale Update Committee (the RUC) — a private committee of specialty physicians — recommends Medicare payment rates to CMS. CMS accepts approximately 90% of RUC recommendations. The RUC is not a federal advisory committee and is not subject to FACA transparency requirements.3
The AHA's own 2017 Regulatory Overload Report quantified the burden: $38.6 billion per year in national compliance costs. The average community hospital spends $7.6 million annually on regulatory compliance, consuming 59 FTEs — over 25% of which are clinical staff pulled from patient care.19 Rural hospitals spend 18% more of total expenses on administrative salaries than urban hospitals.19, 20
Every new regulatory framework — including the proposed Clinical AI Regulatory Framework expected in late 2026 — adds to this fixed cost. Risk-based oversight requires risk assessment staff. Post-deployment monitoring requires monitoring infrastructure. Modernized privacy requires privacy officers and audits. Clear accountability requires legal review and documentation.
Large systems amortize these costs across thousands of beds and billions in revenue. A 5-provider behavioral health clinic eats them whole.
The organizations shaping clinical AI rules are positioning to benefit from the complexity they create:
These are not neutral recommendations. Each position maps to the commercial interests of the organization's membership. The resulting framework will function as a barrier to entry — not because the rules are wrong in principle, but because the cost of compliance is a fixed overhead that scales inversely with organizational size.
| Vector | Mechanism | Who Benefits |
|---|---|---|
| Underpayment | CMS pays below cost (-13% Medicare margin, $130B shortfall) | Government (lower spending) |
| Denial Friction | Payers weaponize process complexity (82% of appeals win, 88% never filed) | Insurance companies |
| Regulatory Capture | Industry-influenced rules raise compliance floor ($8M/yr independent vs $5.1M system) | Large health systems, device manufacturers, compliance industry |
All three disproportionately crush small providers serving the hardest populations. All three depend on complexity being expensive to navigate. All three are vulnerable to the same intervention: making the maze free to run.
Every vector described above — underpayment, denial friction, regulatory capture — ultimately terminates at the same place: the patient. The person who is already sick.
Providers absorb losses, fight denials, and navigate regulatory complexity. But they do not eat those costs permanently. They pass them forward through higher prices, reduced access, longer waits, and narrower networks. The final recipient is always the consumer.
The average American family now spends over $24,000 per year on health insurance premiums and out-of-pocket costs combined.24 Deductibles have risen 10x faster than wages over the past two decades. The "coverage" millions of Americans carry would not survive contact with a serious diagnosis.
The cruelest feature of the system is its timing. Denials, prior authorizations, formulary exceptions, appeals — all of these administrative battles happen while the patient is in active medical crisis. A cancer patient waits for chemotherapy authorization. A behavioral health patient loses medication continuity during a prior auth delay. A parent navigates an appeal while caring for a hospitalized child.
93% of physicians report that prior authorization delays necessary care.7 27% report that prior authorization has led to a serious adverse event for a patient.7 These are not abstract statistics. They are people who got worse — or died — while paperwork moved through a queue.
The system asks the sickest people in the country to become their own claims administrators. Navigate the appeal. Call the insurance company. Get the reference number. Follow up in 7-10 business days. Do this while you are in treatment, in pain, or in crisis. The maze is hard enough for a healthy person with a law degree. For a patient mid-treatment, it is functionally impassable.
In behavioral health — where Nuhra Tech operates — the consumer burden is amplified by the nature of the conditions being treated. Substance use disorder, depression, anxiety, PTSD: these are conditions that directly impair the executive function required to navigate complex administrative systems. The system demands the most from the people least equipped to give it.
SUD patients cycling through treatment face insurance barriers at every transition. New provider, new authorization, new formulary. Continuity of care breaks not because of clinical failure but because the administrative connective tissue does not exist. Every gap is an opportunity for relapse. Every relapse is a new admission, a new set of claims, a new round of denials — and the cycle restarts.
The financial toll compounds the clinical one. Patients in early recovery who receive unexpected medical bills or lose coverage face a stress trigger that directly undermines their treatment. The system designed to help them is actively working against their recovery.
Providers are leaving billions on the table — not because they delivered the wrong care, but because the administrative process is too expensive to execute perfectly. Every missed appeal is revenue owed. Every delayed authorization is a patient who deteriorates. Every compliance gap is margin lost to paperwork.
If you could make perfect compliance the default — every form filled correctly, every authorization submitted on time, every eligible claim followed through to collection — providers recover the revenue they have already earned and patients receive the care they have already been prescribed.
The math is straightforward. 82% of appeals succeed when filed. 88% are never filed. That is not a clinical problem. It is an operational one. Solve the operations and the money follows — money that goes directly to provider margins, clinical capacity, and patient access.
The question is: can you make the maze free to run?
Nuhra Tech exists to make complexity costless for the providers and patients stuck in it. That is not a tagline — it is an engineering thesis. Every administrative process that burns clinician time and delays patient care is a process that should run itself.
The technical vision comes from Ask the Human (askthehuman.com), the AI-accelerated builder studio behind Nuhra's product development. But selling into healthcare at scale requires more than engineering. It requires BD, compliance, and clinical expertise. Nuhra Tech is the vehicle that brings those functions together.
We are already in the maze. Orbiit Recovery — our first product — attacks the care coordination problem. SUD patients bouncing between providers, lost referrals, redundant assessments, no continuity. The system is complex because nobody built the connective tissue. Orbiit is that connective tissue.
The administrative burden is the same problem, different maze. Providers serving the most expensive patient populations are losing money on every government patient, then burning a third of their revenue navigating processes that should be automated. The revenue is already earned. It just needs to be collected.
We start in behavioral health. It is where we already operate, where the Medicaid patient concentration is highest, and where providers are smallest and most under-resourced. Better margins for providers. Better continuity for patients. The playbook scales from there.
Better provider margins. Better patient outcomes. Less time in the maze, more time in the clinic.